Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-02 09:19 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Farallon Capital Partners, L.P. | 5,765,109 9.990% |
710,007 (+14.05%) |
Filing History |
| 2024-02-01 3:50 pm Purchase |
2023-12-31 | 13G | Savara Inc. SVRA |
Farallon Capital Partners, L.P. | 14,326,911 9.990% |
14,326,911 (New Position) |
Filing History |
| 2024-01-30 1:38 pm Sale |
2023-12-31 | 13G | Berenson Acquisition Corp. I BACA |
Farallon Capital Partners, L.P. | 413,113 9.900% |
-2,249,387 (-84.48%) |
Filing History |
| 2024-01-30 11:23 am Purchase |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Farallon Capital Partners, L.P. | 2,205,990 9.990% |
788,073 (+55.58%) |
Filing History |
| 2024-01-26 09:11 am Purchase |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Farallon Capital Partners, L.P. | 2,025,000 9.600% |
475,000 (+30.65%) |
Filing History |
| 2024-01-25 08:28 am Sale |
2023-12-31 | 13G | Forest Road Acquisition Corp. II FRXB |
Farallon Capital Partners, L.P. | 0 0.000% |
-400,000 (Position Closed) |
Filing History |
| 2024-01-24 10:07 am Sale |
2023-12-31 | 13G | AVROBIO, Inc. AVRO |
Farallon Capital Partners, L.P. | 0 0.000% |
-259,667 (Position Closed) |
Filing History |
| 2024-01-22 09:02 am Purchase |
2024-01-12 | 13G | Elevation Oncology, Inc. ELEV |
Farallon Capital Partners, L.P. | 3,100,000 7.300% |
3,100,000 (New Position) |
Filing History |
| 2024-01-19 09:05 am Sale |
2023-12-31 | 13G | Disruptive Acquisition Corporation I DISA |
Farallon Capital Partners, L.P. | 0 0.000% |
-1,400,000 (Position Closed) |
Filing History |
| 2024-01-18 08:58 am Sale |
2023-12-31 | 13G | ARYA Sciences Acquisition Corp IV ARYD |
Farallon Capital Partners, L.P. | 200,000 4.800% |
-600,000 (-75.00%) |
Filing History |
| 2024-01-02 2:25 pm Purchase |
2023-12-20 | 13G | The New York Times Company NYT |
Farallon Capital Partners, L.P. | 9,476,791 5.800% |
9,476,791 (New Position) |
Filing History |
| 2023-12-08 4:39 pm Purchase |
2023-12-06 | 13D | Cazoo Group Ltd CZOOF |
Farallon Capital Partners, L.P. | 7,142 14.600% |
7,142 (New Position) |
Filing History |
| 2023-11-09 5:18 pm Purchase |
2023-10-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 6,762,480 6.200% |
6,762,480 (New Position) |
Filing History |
| 2023-11-09 5:18 pm Purchase |
2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Farallon Capital Partners, L.P. | 3,961,602 7.100% |
3,961,602 (New Position) |
Filing History |
| 2023-11-07 5:04 pm Unchanged |
2023-11-03 | 13D | Cazoo Group Ltd CZOO |
Farallon Capital Partners, L.P. | 10,000 2.500% |
0 (Unchanged) |
Filing History |
| 2023-10-16 4:45 pm Purchase |
2023-10-04 | 13G | Aramark ARMK |
Farallon Capital Partners, L.P. | 15,381,069 5.900% |
383,065 (+2.55%) |
Filing History |
| 2023-09-22 5:05 pm Unchanged |
2023-09-20 | 13D | Cazoo Group Ltd CZOO |
Farallon Capital Partners, L.P. | 10,000 2.500% |
0 (Unchanged) |
Filing History |
| 2023-09-22 3:20 pm Purchase |
2023-09-13 | 13G | Beam Therapeutics Inc. BEAM |
Farallon Capital Partners, L.P. | 4,113,469 5.200% |
713,548 (+20.99%) |
Filing History |
| 2023-08-11 5:17 pm Purchase |
2023-08-02 | 13D | Chinook Therapeutics, Inc. KDNY |
Farallon Capital Partners, L.P. | 7,110,000 9.900% |
7,110,000 (New Position) |
Filing History |
| 2023-08-10 3:57 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
Farallon Capital Partners, L.P. | 151,505 9.900% |
151,505 (New Position) |
Filing History |